WSJ: are #coronavirus vaccines riskier than advertised?

Wall Street Journal opinion: “not a single published study has demonstrated that patients with a prior infection benefit from Covid-19 vaccination. That this isn’t readily acknowledged by the CDC or Anthony Fauci is an indication of how deeply entangled pandemic politics is in science.”

WSJ Opinion: Are Covid Vaccines Riskier Than Advertised?

 

Israel: 50% vaccine breakthrough for #coronavirus cases in the last month

 

 

Photo by CDC on Unsplash

 

 

So what is Plan B if the vaccines fail?

14th June 2021: We’ve spent two days scouring the internet looking for Plan B for what happens in the event of complete Covid-19 vaccine failure. So what does happen if the vaccines fail? Here is what we have found so far:

Actually, we found no results. It seems that no one is even asking the question. Perhaps it’s time to start that conversation?

 

Global Covid-19 Map courtesy of John Hopkins University

 


 

** UPDATE 31ST JULY 2021 **  Finally, the UK government takes a peek out of the front screen to see what is oncoming rather than checking the rear-view mirror to look at the pile-up that has just occurred.

*Warning*  The report contains plenty of dire predictions but proposes no solutions whatsoever.

UK SAGE Bombshell Report: The Long Term Evolution of Sars-CoV-2

 


 

** UPDATE 15th AUGUST 2021 ** 

“UK Ministers are being pressed to reveal what contingency plans are in place to deal with a future Covid variant that evades current vaccines, amid warnings from scientific advisers that such an outcome could set the battle against the pandemic back a year or more.”  

Guardian article

 


 

** UPDATE 27th AUGUST 2021 **

If you have two hours to waste, you could spend it reading this new European view on the future of Sars-CoV-2:

A look into the future of the COVID-19 pandemic in Europe: an expert consultation

In our opinion, this article is by far the poorest attempt yet to predict the future course of the pandemic, relying largely on outdated information and stale groupthink. For example:

What can be expected in the autumn and winter of 2021 depends substantially on what happens in the summer; specifically, the success of vaccination programs both in Europe and worldwide, and the emergence and spread of (new) VOCs. Compared to the summer, autumn and winter bring the additional complication of unfavorable seasonal effects. The seasonality of coronaviruses is expected to increase infections in the autumn and winter months…..”

It’s a 0/10 from us.

 


 

** UPDATE 14TH SEPTEMBER 2021 **

The UK has another stab at Plan B:

 

The UK announces its winter Covid plans

 

Er, yeah, I guess we’ll keep searching…

 


 

 

USA: #coronavirus vaccine breakthrough infections are potentially contagious

Researchers reported that among 20 fully-vaccinated healthcare workers with vaccine breakthrough COVID-19 cases, all were infected with coronavirus variants. An earlier study had linked breakthrough infections with low viral loads, suggesting low transmission risks, but “we found many samples in our breakthrough cohort with high viral load,” said coauthor Pavitra Roychoudhury of the University of Washington. CONTAGIOUS: “Our work suggests that not all breakthrough infections are at low risk of initiating transmission and, if they did, these infections could lead to the continued spread of variants of concern, particularly in areas with low vaccination rates.”

The CDC has genetic data for virus samples from 555 vaccine breakthrough infections. Mutated variants of the coronavirus, including those first seen in the UK and South Africa, accounted for 64% of the breakthroughs.

Vancouver Sun report

Medrxix preprint – Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State

China’s first mRNA #coronavirus vaccine ready for final stage trials overseas

China’s first domestically developed mRNA vaccine is ready to start its final stage trials overseas next month.The vaccine – which uses the same advanced revolutionary techniques as the drugs developed by Pfizer-BioNTech and Moderna – is at the end of phase 2 human trials and will start large-scale phase 3 trials next month, Ying Bo, founder and chief executive of Suzhou Abogen Biosciences, told China National Radio.

The vaccine, known as ARCoV, has been jointly developed by Abogen, the Academy of Military Science and Walvax Biotechnology.

SCMP report